ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,615.35
0.55%
US Tech 100
19,804.00
0.64%
Dow Jones
40,000.90
0.62%
Brent Oil
84.57
0.00%
Bitcoin
59,312.93
0.13%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Protara Therapeutics Inc (TARA)

  7. Protara Therapeutics Inc (TARA) News

TARA

Protara Therapeutics (TARA)

Protara Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TARA
DateTimeSourceHeadlineSymbolCompany
09/23/20209:09AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TARAProtara Therapeutics Inc
09/23/20209:06AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:TARAProtara Therapeutics Inc
09/22/20208:59AMEdgar (US Regulatory)Registration of Additional Securities (up to 20%) (s-3mef)NASDAQ:TARAProtara Therapeutics Inc
09/22/20208:12AMGlobeNewswire Inc.Protara Therapeutics Announces Pricing of $147.6 Million of Securities in Concurrent Public Offerings of Common Stock and Pre...NASDAQ:TARAProtara Therapeutics Inc
09/21/20204:26PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:TARAProtara Therapeutics Inc
09/21/20204:24PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:TARAProtara Therapeutics Inc
09/21/20204:01PMGlobeNewswire Inc.Protara Therapeutics Announces Proposed Concurrent Public Offerings of Common Stock and Preferred StockNASDAQ:TARAProtara Therapeutics Inc
09/14/20204:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
09/10/20203:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
09/08/20207:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TARAProtara Therapeutics Inc
09/04/20204:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
09/02/20205:49PMGlobeNewswire Inc.Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TARAProtara Therapeutics Inc
09/01/20204:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
08/28/20203:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
08/24/20209:50AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
08/20/20204:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
08/18/20205:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
08/03/20207:00AMGlobeNewswire Inc.Protara Therapeutics Announces Second Quarter 2020 Financial Results and Business OverviewNASDAQ:TARAProtara Therapeutics Inc
07/31/20204:22PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TARAProtara Therapeutics Inc
07/29/20204:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
07/28/20207:00AMGlobeNewswire Inc.Protara Therapeutics Receives Rare Pediatric Disease Designation for TARA-002 for the Treatment of Lymphatic MalformationsNASDAQ:TARAProtara Therapeutics Inc
07/27/20204:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
07/27/20204:43PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TARAProtara Therapeutics Inc
07/27/20204:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
07/24/20207:00AMGlobeNewswire Inc.Protara Therapeutics Announces Appointment of Barry P. Flannelly to Board of DirectorsNASDAQ:TARAProtara Therapeutics Inc
07/23/20204:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
07/16/20204:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TARAProtara Therapeutics Inc
07/14/20204:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
07/13/20202:57PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
07/02/20207:59PMGlobeNewswire Inc.CORRECTION – Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TARAProtara Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TARA

Your Recent History

COIN
XRPUSD
Ripple
USOTC
MVNT
Movement Industries (PK)
USOTC
GRST
Ethema Health (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
IQST
iQSTEL (QX)
USOTC
ERHE
ERHC Energy (CE)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
VPLM
Voip Pal Com (QB)
COIN
BTCUSD
Bitcoin
USOTC
HIRU
Hiru (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
AABB
Asia Broadband (PK)
USOTC
RDGL
Vivos (QB)
USOTC
BIEL
Bioelectronics (PK)
NASDAQ
AVXL
Anavex Life Sciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved